Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 5,5-fused arylene or heteroarylene hepatitis C virus inhibitors

5,5-fused arylene or heteroarylene hepatitis C virus inhibitors

US Patent 8362068 · Granted Jan 29, 2013

Estimated economic value: $10,489,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

PRMT5 inhibitors2024
PRMT5 inhibitors2024
Non-fused thiophene derivatives and their uses2023
Cyclic phosphate substituted nucleoside derivatives for the treatment of liver d2023
Cyclic phosphate substituted nucleoside derivatives for the treatment of liver d2023
Cyclic phosphate substituted nucleoside derivatives for the treatment of liver d2023
Fused thiophene derivatives and their uses2023
Adenine derivatives as protein kinase inhibitors2022
Antiviral benzyl-amine phosphodiamide compounds2021
Carbocyclic nucleoside reverse transcriptase inhibitors2021
Carbocyclic nucleoside reverse transcriptase inhibitors2021
Cyclic phosphate substituted nucleoside compounds and methods of use thereof for2021